DOCSLIB.ORG

Best Practices in Managing Hyperkalemia in Chronic Kidney

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

TREATMENT OF HYPERKALEMIA IN CKD REFERENCES The steps to address hyperkalemia include stabilization, redistribution, and excretion/removal of potassium. + 1. Tran HA. Extreme hyperkalemia. 11. Inker LA, Astor BC, Fox CH, et al. KDOQI U.S. Best Practices in Managing South Med J. 2005;98:729-732. commentary on the 2012 KDIGO clinical Table 3. Summary of interventions used for acute or chronic treatment of hyperkalemia6 practice guideline for the evaluation and K 2. Gumz ML, Rabinowitz L, Wingo CS. An HYPERKALEMIA integrated view of potassium homeostasis. management of CKD. Am J Kidney Dis. May Treatment Route of Onset/ Mechanism Comments N Engl J Med. 2015;373:60-72. 2014;63(5):713-735. in Chronic Kidney Disease administration duration 3. Alvo M, Warnock DG. Hyperkalemia. 12. Mercier K, Smith H, Biederman J. Renin- West J Med. 1984;141:666-671. angiotensin-aldosterone system 6.8 mmol of calcium, corresponding Intravenous (acute) 1-3 min Membrane Does not affect serum potassium level inhibition: overview of the therapeutic 4. Einhorn LM, Zhan M, Hsu VD, et al. The frequency of to 10 ml CaCl (10%)* or 30 ml 30-60 min potential stabilization Effect measured by normalization of electrocardiographic changes use of angiotensin-converting enzyme calcium gluconate (10%) solutions Dose can be repeated if no effects noted hyperkalemia and its significance in chronic kidney inhibitors, angiotensin receptor blockers, Caution advised in patients receiving digoxin disease. Arch Intern Med. 2009;169:1156-1162. mineralocorticoid receptor antagonists, 50-250 ml hypertonic saline (3-5%)** Intravenous (acute) 5-10 min Membrane Efficacy only in hyponatremic patients 5. Jain N, Kotla S, Little BB, et al. Predictors of and direct renin inhibitors. Prim Care. ~2 h potential stabilization hyperkalemia and death in patients with 2014;41:765-778. cardiac and renal disease. Am J Cardiol. 50-100 mmol sodium bicarbonate Intravenous (acute) 5-10 min Redistribution Sodium may worsen pre-existing hypertension and heart failure 13. Vassalotti JA, Centor R, Turner BJ, et al; U.S. 2012;109:1510-1513. or oral (chronic) ~2 h Efficacy questioned for acute treatment of patients on dialysis Kidney Disease Outcomes Quality Initiative 6. Kovesdy CP. Management of hyperkalaemia (KDOQI). A practical approach to detection 10 units of regular insulin Intravenous (acute) 30 min Redistribution Administer with 50 g of glucose intravenously to prevent hypoglycemia in chronic kidney disease. Nat Rev Nephrol. and management of chronic kidney disease 4-6 h 2014;10:653-662. for the primary care clinician [Epub ahead of ß2-receptor agonists: Intravenous or 30 min Redistribution Effect independent of insulin and aldosterone 7. Sarafidis PA, Blacklock R, Wood E, et al. print September 18 2015]. Am J Med. 2015. 10-20 mg aerosol (nebulized) or nebulized (both 2-4 h Caution in patients with known coronary artery disease 0.5mg in 100ml of 5% dextrose in acute) Prevalence and factors associated with 14. Lehnhardt A, Kemper MJ. Pathogenesis, water (intravenous) hyperkalemia in predialysis patients followed in diagnosis, and management of a low-clearance clinic. Clin J Am Soc Nephrol. hyperkalemia. Pediatr Nephrol. March 40 mg furosemide or equivalent Intravenous (acute) Varies Excretion Loop diuretics for acute intervention 2012;7:1234-1241. 2011;26:377-384. dose of other loop diuretic. Higher or oral (chronic) Until diuresis Loop or thiazide diuretics for chronic management; loop diuretic for GFR <40 ml/min/1.73 m2 15 8. Turgut F, Balogun RA, Abdel-Rahman 15. Sarafidis PA, Georgianos PI, Bakris GL. doses may be needed in patients present or May not be effective in patients with reduced GFR EM. Renin-angiotensin-aldosterone system with advanced CKD longer Advances in treatment of hyperkalemia blockade effects on the kidney in the elderly: in chronic kidney disease. Expert Opin Fludrocortisone acetate ≥0.1 mg Oral (chronic) NA Excretion In patients with aldosterone deficiency, large doses might be needed to effectively lower benefits and limitations. Clin J Am Soc Pharmacother. 2015;16:2205-2215. (up to 0.4-1.0 mg daily) potassium levels Nephrol. 2010;5:1330-1339. Sodium retention, edema, and hypertension might occur, and acceleration of kidney and 16. U.S. Food and Drug Administration (FDA). cardiovascular disease 9. Xie X, Liu Y, Perkovic V, et al. Renin-angiotensin Kayexalate. http://www.accessdata.fda.gov/ system inhibitors and kidney and drugsatfda_docs/label/2011/011287s023lbl. Cation exchange resins Oral or rectal (either 1-2 h Excretion Cases of intestinal necrosis, which may be fatal, and other serious GI adverse events have cardiovascular outcomes in patients with pdf. Updated December 2010. Accessed Sodium polystyrene sulfonate acute or chronic), �4-6 h been reported16 CKD: a Bayesian Network meta-analysis of December 22 2015. 25-50 g with or without May cause hypokalemia and electrolyte disturbances16 randomized clinical trials [Epub ahead of print sorbitol Cannot be used in medical emergencies16 17. U.S. Food and Drug Administration (FDA). FDA › Hyperkalemia in Chronic Kidney Disease (CKD) 16 November 17 2015]. Am J Kidney Dis. 2015. Caution in patients with heart failure due to sodium load approves new drug to treat hyperkalemia. › Treatment with RAAS Inhibitors (RAASi) in CKD 10. Kidney Disease: Improving Global Outcomes Cation exchange polymer Oral (either acute 7 h Excretion Binds with many other oral medications (in vitro binding studies), separate the dosing of other http://www.fda.gov/NewsEvents/Newsroom/ (KDIGO) CKD Work Group. KDIGO 2012 › Diagnosis and Evaluation of Hyperkalemia Patiromer 8.4, 16.8, or 25.2 g or chronic) ~48 h oral medications by at least 6 hours 17 *** PressAnnouncements/ucm468546.htm. Should not be used as an emergency treatment for life-threatening hyperkalemia because clinical practice guideline for the evaluation Published October 22 2015. Accessed › Treatment of Hyperkalemia in CKD of its delayed onset of action17 and management of chronic kidney disease. November 24 2015. May result in hypokalemia or hypomagnesemia17 Kidney Int Suppls. 2013;3:1-150. Dialysis Hemodialysis Within Removal Effects of dialysis on serum sodium, bicarbonate, calcium and/or magnesium levels can affect results (acute or chronic); minutes For chronic hemodialysis, missed treatments and 2-day interdialytic interval may have a Peritoneal dialysis Until end of negative impact on outcomes. (chronic) dialysis or This publication has been sponsored and longer**** developed in collaboration with Relypsa, Inc. 30 East 33rd Street *CaCl is caustic and could damage peripheral veins. **Limited data available from clinical studies. ***Clinical studies being done to assess the clinical significance of the in vitro interaction. ****Effects can New York, NY 10016 last for an unspecified length of time, depending on ongoing potassium intake or cellular redistribution. Abbreviations: CKD, chronic kidney disease; GFR, glomerular filtration rate; GI, gastrointestinal; NA, not 800.622.9010 applicable. | Adapted with permission from Kovesdy CP. Management of hyperkalaemia in chronic kidney disease. Nat Rev Nephrol, 2014;10:659-662. Copyright 2014 by Macmillan Publishers Limited. www.kidney.org © 2016 National Kidney Foundation, Inc. 02-10-7259_LBG HYPERKALEMIA TREATMENT WITH RAASi DIAGNOSIS AND EVALUATION IN CKD IN CKD OF HYPERKALEMIA The definition of hyperkalemia varies and limits such as >5.5, Studies show that use of ACEIs or ARBs in people with CKD reduces the Hyperkalemia is often asymptomatic, but patients may complain 1 >6.0, or >7.0 mEq/L are used to indicate severity. Repetitive Table 2. Chronic Risk Factors for risk for kidney failure and cardiovascular events, but their use contributes of nonspecific symptoms such as palpitations, nausea, muscle consecutive measures of serum potassium are needed Hyperkalemia in CKD 5, 6, 7, 8 to hyperkalemia.9 The clinical practice guidelines for the use of RAASi in pain, weakness, or paresthesia. Moderate and especially severe to determine if hyperkalemia is sustained or a transient event. CKD are as follows:10, 11 hyperkalemia can lead to cardiotoxicity, which can be fatal. The Many factors affect potassium homeostasis.2 cause of hyperkalemia has to be determined to prevent future episodes. 14 Risk Factor Due To KDIGO Guidelines suggest that an ARB or ACEI be used in diabetic adults with CKD and urine albumin excretion 30-300 mg/24 hours (or equivalent). (2D) Potassium intake Increased dietary potassium intake from Table 1. Acute Versus Chronic Hyperkalemia 3, 4 salt substitute, potassium-rich heart-healthy KDIGO Guidelines recommend that an ARB or ACEI be used in Emergency diagnostic Elective/etiologic diets, and herbal supplements both diabetic and nondiabetic adults with CKD and urine albumin workup:14 workup:14 Acute Hyperkalemia Chronic Hyperkalemia Metabolic acidosis Potassium shift from the intracellular to the excretion >300 mg/24 hours (or equivalent). (1B) extracellular space 1. Assessment of cardiac function, 1. Comprehensive laboratory workup There is insufficient evidence to recommend combining an kidneys, and urinary tract Caused by abnormal net release of Caused by impairment of RAASi Treatment with ACEIs and ARBs block the ACEI with ARBs to prevent progression of CKD. (Not Graded) 2. Review of medication used potassium from cells, often due to potassium excretory process renin-angiotensin system and cause lower 2. Assessment of hydration status trauma, metabolic acidosis (depends and/or increased
Recommended publications
  • 1 Fluid and Elect. Disorders of Serum Sodium Concentration

    1 Fluid and Elect. Disorders of Serum Sodium Concentration

    DISORDERS OF SERUM SODIUM CONCENTRATION Bruce M. Tune, M.D. Stanford, California Regulation of Sodium and Water Excretion Sodium: glomerular filtration, aldosterone, atrial natriuretic factors, in response to the following stimuli. 1. Reabsorption: hypovolemia, decreased cardiac output, decreased renal blood flow. 2. Excretion: hypervolemia (Also caused by adrenal insufficiency, renal tubular disease, and diuretic drugs.) Water: antidiuretic honnone (serum osmolality, effective vascular volume), renal solute excretion. 1. Antidiuresis: hyperosmolality, hypovolemia, decreased cardiac output. 2. Diuresis: hypoosmolality, hypervolemia ~ natriuresis. Physiologic changes in renal salt and water excretion are more likely to favor conservation of normal vascular volume than nonnal osmolality, and may therefore lead to abnormalities of serum sodium concentration. Most commonly, 1. Hypovolemia -7 salt and water retention. 2. Hypervolemia -7 salt and water excretion. • HYFERNATREMIA Clinical Senini:: Sodium excess: salt-poisoning, hypertonic saline enemas Primary water deficit: chronic dehydration (as in diabetes insipidus) Mechanism: Dehydration ~ renal sodium retention, even during hypernatremia Rapid correction of hypernatremia can cause brain swelling - Management: Slow correction -- without rapid administration of free water (except in nephrogenic or untreated central diabetes insipidus) HYPONA1REMIAS Isosmolar A. Factitious: hyperlipidemia (lriglyceride-plus-plasma water volume). B. Other solutes: hyperglycemia, radiocontrast agents,. mannitol.
  • Study Guide Medical Terminology by Thea Liza Batan About the Author

    Study Guide Medical Terminology by Thea Liza Batan About the Author

    Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails ­proficiency­in­communicating­with­healthcare­professionals­such­as­physicians,­nurses,­ or dentists.
  • Hyperkalemia Masked by Pseudo-Stemi Infarct Pattern and Cardiac Arrest Shareez Peerbhai1 , Luke Masha2, Adrian Dasilva-Deabreu1 and Abhijeet Dhoble1,2*

    Hyperkalemia Masked by Pseudo-Stemi Infarct Pattern and Cardiac Arrest Shareez Peerbhai1 , Luke Masha2, Adrian Dasilva-Deabreu1 and Abhijeet Dhoble1,2*

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector Peerbhai et al. International Journal of Emergency Medicine (2017) 10:3 International Journal of DOI 10.1186/s12245-017-0132-0 Emergency Medicine CASEREPORT Open Access Hyperkalemia masked by pseudo-stemi infarct pattern and cardiac arrest Shareez Peerbhai1 , Luke Masha2, Adrian DaSilva-DeAbreu1 and Abhijeet Dhoble1,2* Abstract Background: Hyperkalemia is a common electrolyte abnormality and has well-recognized early electrocardiographic manifestations including PR prolongation and symmetric T wave peaking. With severe increase in serum potassium, dysrhythmias and atrioventricular and bundle branch blocks can be seen on electrocardiogram. Although cardiac arrest is a worrisome consequence of untreated hyperkalemia, rarely does hyperkalemia electrocardiographically manifest as acute ischemia. Case presentation: We present a case of acute renal failure complicated by malignant hyperkalemia and eventual ventricular fibrillation cardiac arrest. Recognition of this disorder was delayed secondary to an initial ECG pattern suggesting an acute ST segment elevation myocardial infarction (STEMI). Emergent coronary angiography performed showed no evidence of coronary artery disease. Conclusions: Pseudo-STEMI patterns are rarely seen in association with acute hyperkalemia and are most commonly described with patient without acute cardiac symptomatology. This is the first such case presenting concurrently with cardiac arrest. A brief review of this rare pseudo-infarct pattern is also given. Keywords: Cardiac arrest, Hyperkalemia, Myocardial infarction, STEMI, ECG Background Case presentation Hyperkalemia that manifests with electrocardiographic A 27-year-old Caucasian male with a past medical his- findings of an ST segment elevation myocardial infarc- tory of hypertension presented to the emergency room tion (STEMI) is very rare.
  • HANDOUT #1 CONCEPT INTRODUCTION PRESENTATION: PERFUSION Topic Description Definition of Perfusion the Passage of Oxygenated Capi

    HANDOUT #1 CONCEPT INTRODUCTION PRESENTATION: PERFUSION Topic Description Definition of Perfusion the Passage of Oxygenated Capi

    HANDOUT #1 CONCEPT INTRODUCTION PRESENTATION: PERFUSION Topic Description Definition of Perfusion The passage of oxygenated capillary blood through body tissues. Peripheral perfusion is passage (flow) of blood to the extremities of the body. Central perfusion is passage (flow) of blood to major body organs, including the heart and lungs. Scope of Perfusion Perfusion can be viewed on a continuum as adequate on one end and inadequate, decreased, or impaired on the other. Decreased Perfusion can range from minimal to severe. Ischemia refers to decreased Perfusion, while infarction is complete tissue death due to severe decreased Perfusion. Risk Factors/Populations at Risk for Examples of risk factors or populations at risk Impaired Perfusion for impaired Perfusion can be categorized as modifiable (can be changed) and nonmodifiable (cannot be changed) Modifiable factors include: • Obesity • Lack of physical activity/sedentary lifestyle • Smoking Nonmodifiable factors include age, gender, and race/ethnicity. Groups at risk for impaired Perfusion include those who are of advanced age (due to less elastic arterial vessels as a result of aging) and those who are African American and Hispanic. These racial/ethnic groups are most at risk for chronic diseases that can affect Perfusion such as diabetes mellitus, hypertension, hyperlipidemia, and peripheral vascular disease. The cause of these variations is not known, but dietary and environmental factors may contribute to the higher incidence of chronic disease in these groups. Newborns and infants who have congenital heart anomalies are also at risk for impaired central Perfusion. Many of these defects can be surgically repaired to regain adequate Perfusion. Physiologic Consequences of Impaired Consequences of impaired Perfusion vary Perfusion depending on the degree of impairment.
  • What Are the Health Effects from Exposure to Carbon Monoxide?

    What Are the Health Effects from Exposure to Carbon Monoxide?

    CO Lesson 2 CARBON MONOXIDE: LESSON TWO What are the Health Effects from Exposure to Carbon Monoxide? LESSON SUMMARY Carbon monoxide (CO) is an odorless, tasteless, colorless and nonirritating Grade Level: 9 – 12 gas that is impossible to detect by an exposed person. CO is produced by the Subject(s) Addressed: incomplete combustion of carbon-based fuels, including gas, wood, oil and Science, Biology coal. Exposure to CO is the leading cause of fatal poisonings in the United Class Time: 1 Period States and many other countries. When inhaled, CO is readily absorbed from the lungs into the bloodstream, where it binds tightly to hemoglobin in the Inquiry Category: Guided place of oxygen. CORE UNDERSTANDING/OBJECTIVES By the end of this lesson, students will have a basic understanding of the physiological mechanisms underlying CO toxicity. For specific learning and standards addressed, please see pages 30 and 31. MATERIALS INCORPORATION OF TECHNOLOGY Computer and/or projector with video capabilities INDIAN EDUCATION FOR ALL Fires utilizing carbon-based fuels, such as wood, produce carbon monoxide as a dangerous byproduct when the combustion is incomplete. Fire was important for the survival of early Native American tribes. The traditional teepees were well designed with sophisticated airflow patterns, enabling fires to be contained within the shelter while minimizing carbon monoxide exposure. However, fire was used for purposes other than just heat and cooking. According to the historian Henry Lewis, Native Americans used fire to aid in hunting, crop management, insect collection, warfare and many other activities. Today, fire is used to heat rocks used in sweat lodges.
  • Routine Adult Brain Perfusion

    Routine Adult Brain Perfusion

    Adult Brain Perfusion CT Protocols Version 2.0 3/1/2016 DISCLAIMER: TO THE EXTENT ALLOWED BY LOCAL LAW, THIS INFORMATION IS PROVIDED TO YOU BY THE AMERICAN ASSOCIATION OF PHYSICISTS IN MEDICINE, A NON-PROFIT ORGANIZATION ORGANIZED TO PROMOTE THE APPLICATION OF PHYSICS TO MEDICINE AND BIOLOGY, ENCOURAGE INTEREST AND TRAINING IN MEDICAL PHYSICS AND RELATED FIELDS ("AAPM"), 'AS IS' WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, WHETHER ORAL OR WRITTEN, EXPRESS OR IMPLIED. AAPM SPECIFICALLY DISCLAIMS ANY IMPLIED WARRANTIES OR CONDITIONS OF MERCHANTABILITY, SATISFACTORY QUALITY, NONINFRINGEMENT AND FITNESS FOR A PARTICULAR PURPOSE. SOME JURISDICTIONS DO NOT ALLOW EXCLUSIONS OF IMPLIED WARRANTIES OR CONDITIONS, SO THE ABOVE EXCLUSION MAY NOT APPLY TO YOU. YOU MAY HAVE OTHER RIGHTS THAT VARY ACCORDING TO LOCAL LAW. TO THE EXTENT ALLOWED BY LOCAL LAW, IN NO EVENT WILL AAPM OR ITS SUBSIDIARIES, AFFILIATES OR VENDORS BE LIABLE FOR DIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL OR OTHER DAMAGES (INCLUDING LOST PROFIT, LOST DATA, OR DOWNTIME COSTS), ARISING OUT OF THE USE, INABILITY TO USE, OR THE RESULTS OF USE OF THE PROVIDED INFORMATION, WHETHER BASED IN WARRANTY, CONTRACT, TORT OR OTHER LEGAL THEORY, AND WHETHER OR NOT ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. YOUR USE OF THE INFORMATION IS ENTIRELY AT YOUR OWN RISK. THIS INFORMATION IS NOT MEANT TO BE USED AS A SUBSTITUTE FOR THE REVIEW OF SCAN PROTOCOL PARAMETERS BY A QUALIFIED AND CERTIFIED PROFESSIONAL. USERS ARE CAUTIONED TO SEEK THE ADVICE OF A QUALIFIED AND CERTIFIED PROFESSIONAL BEFORE USING ANY PROTOCOL BASED ON THE PROVIDED INFORMATION. AAPM IS NOT RESPONSIBLE FOR A USER'S FAILURE TO VERIFY OR CONFIRM APPROPRIATE PERFORMANCE OF THE PROVIDED SCAN PARAMETERS.
  • Electrolyte Disorders and Arrhythmogenesis

    Electrolyte Disorders and Arrhythmogenesis

    Cardiology Journal 2011, Vol. 18, No. 3, pp. 233–245 Copyright © 2011 Via Medica REVIEW ARTICLE ISSN 1897–5593 Electrolyte disorders and arrhythmogenesis Nabil El-Sherif1, Gioia Turitto2 1State University of NY, Downstate Medical Center and NY Harbor VA Healthcare System, Brooklyn, NY, USA 2Methodist University Hospital, Brooklyn, NY, USA Abstract Electrolyte disorders can alter cardiac ionic currents kinetics and depending on the changes can promote proarrhythmic or antiarrhythmic effects. The present report reviews the mecha- nisms, electrophysiolgical (EP), electrocardiographic (ECG), and clinical consequences of elec- trolyte disorders. Potassium (K+) is the most abundent intracellular cation and hypokalemia is the most commont electrolyte abnormality encountered in clinical practice. The most signifcant ECG manifestation of hypokalemia is a prominent U wave. Several cardiac and + non cardiac drugs are known to suppress the HERG K channel and hence the IK, and especially in the presence of hypokalemia, can result in prolonged action potential duration and QT interval, QTU alternans, early afterdepolarizations, and torsade de pointes ventricu- lar tachyarrythmia (TdP VT). Hyperkalemia affects up to 8% of hospitalized patients mainly in the setting of compromised renal function. The ECG manifestation of hyperkalemia de- pends on serum K+ level. At 5.5–7.0 mmol/L K+, tall peaked, narrow-based T waves are seen. At > 10.0 mmol/L K+, sinus arrest, marked intraventricular conduction delay, ventricular techycardia, and ventricular fibrillation can develop. Isolated abnormalities of extracellular calcium (Ca++) produce clinically significant EP effects only when they are extreme in either direction. Hypocalcemia, frequently seen in the setting of chronic renal insufficiency, results in prolonged ST segment and QT interval while hypercalcemia, usually seen with hyperparathy- roidism, results in shortening of both intervals.
  • MEDICAL STATEMENT Participant Record (Confidential Information) Please Read Carefully Before Signing

    MEDICAL STATEMENT Participant Record (Confidential Information) Please Read Carefully Before Signing

    MEDICAL STATEMENT Participant Record (Confidential Information) Please read carefully before signing. This is a statement in which you are informed of some potential risks established safety procedures are not followed, however, there are involved in scuba diving and of the conduct required of you during the increased risks. scuba training program. Your signature on this statement is required for To scuba dive safely, you should not be extremely overweight or you to participate in the scuba training program offered out of condition. Diving can be strenuous under certain conditions. Your respiratory and circulatory systems must be in good health. All body air by_____________________________________________________and spaces must be normal and healthy. A person with coronary disease, a Instructor current cold or congestion, epilepsy, a severe medical problem or who is under the influence of alcohol or drugs should not dive. If you have _______________________________________________located in the asthma, heart disease, other chronic medical conditions or you are tak- Facility ing medications on a regular basis, you should consult your doctor and the instructor before participating in this program, and on a regular basis city of_______________________, state/province of _______________. thereafter upon completion. You will also learn from the instructor the important safety rules regarding breathing and equalization while scuba Read this statement prior to signing it. You must complete this diving. Improper use of scuba equipment can result in serious injury. You Medical Statement, which includes the medical questionnaire section, to must be thoroughly instructed in its use under direct supervision of a enroll in the scuba training program. If you are a minor, you must have qualified instructor to use it safely.
  • Medical Term Lay Term(S)

    Medical Term Lay Term(S)

    MEDICAL TERM LAY TERM(S) ABDOMINAL Pertaining to body cavity below diaphragm which contains stomach, intestines, liver, and other organs ABSORB Take up fluids, take in ACIDOSIS Condition when blood contains more acid than normal ACUITY Clearness, keenness, esp. of vision - airways ACUTE New, recent, sudden ADENOPATHY Swollen lymph nodes (glands) ADJUVANT Helpful, assisting, aiding ADJUVANT Added treatment TREATMENT ANTIBIOTIC Drug that kills bacteria and other germs ANTIMICROBIAL Drug that kills bacteria and other germs ANTIRETROVIRAL Drug that inhibits certain viruses ADVERSE EFFECT Negative side effect ALLERGIC REACTION Rash, trouble breathing AMBULATE Walk, able to walk -ATION -ORY ANAPHYLAXIS Serious, potentially life threatening allergic reaction ANEMIA Decreased red blood cells; low red blood cell count ANESTHETIC A drug or agent used to decrease the feeling of pain or eliminate the feeling of pain by general putting you to sleep ANESTHETIC A drug or agent used to decrease the feeling of pain or by numbing an area of your body, local without putting you to sleep ANGINA Pain resulting from insufficient blood to the heart (ANGINA PECTORIS) ANOREXIA Condition in which person will not eat; lack of appetite ANTECUBITAL Area inside the elbow ANTIBODY Protein made in the body in response to foreign substance; attacks foreign substance and protects against infection ANTICONVULSANT Drug used to prevent seizures ANTILIPIDEMIC A drug that decreases the level of fat(s) in the blood ANTITUSSIVE A drug used to relieve coughing ARRHYTHMIA Any change from the normal heartbeat (abnormal heartbeat) ASPIRATION Fluid entering lungs ASSAY Lab test ASSESS To learn about ASTHMA A lung disease associated with tightening of the air passages ASYMPTOMATIC Without symptoms AXILLA Armpit BENIGN Not malignant, usually without serious consequences, but with some exceptions e.g.
  • Cerebral Salt Wasting: Truths, Fallacies, Theories, and Challenges

    Cerebral Salt Wasting: Truths, Fallacies, Theories, and Challenges

    Journal Article Page 1 of 10 Use of this content is subject to the Terms and Conditions of the MD Consult web site. Critical Care Medicine Volume 30 • Number 11 • November 2002 Copyright © 2002 Lippincott Williams & Wilkins REVIEW ARTICLE Cerebral salt wasting: Truths, fallacies, theories, and challenges Sheila Singh, MD; Desmond Bohn, MB; Ana P. C. P. Carlotti; Michael Cusimano, MD; James T. Rutka; Mitchell L. Halperin, MD From the Departments of Pediatric Neurosurgery (SS, JTR) and Critical Care Medicine (DB), Hospital for Sick Children, Toronto, Canada; the Department of Anaesthesiology, University of Toronto, Toronto, Canada (DB); the Department of Pediatrics, Universidade de Sao Paulo, Ribeirao Preto, Brazil (APCPC); and the Department of Neurosurgery (MC) and Renal Division (MLH), St. Michael’s Hospital, University of Toronto, Toronto, Canada. Supported, in part, by a grant from Physicians Services Incorporated. Address requests for reprints to: Mitchell L. Halperin, MD, Division of Nephrology, St. Michael’s Hospital, Annex, 38 Shuter Street, Toronto, Ontario M5B 1A6, Canada. E-mail: [email protected] Cerebral salt wasting is a diagnosis of exclusion that requires a natriuresis in a patient with a contracted effective arterial blood volume and the absence of another cause for this excretion of Na+ . Background: The reported prevalence of cerebral salt wasting has increased in the past three decades. A cerebral lesion and a large natriuresis without a known stimulus to excrete so much sodium (Na+ ) constitute its essential two elements. Objectives: To review the topic of cerebral salt wasting. There is a diagnostic problem because it is difficult to confirm that a stimulus for the renal excretion of Na+ is absent.
  • The Medical Examination of Divers - a Guide for Physicians', Published by the Labour Department

    The Medical Examination of Divers - a Guide for Physicians', Published by the Labour Department

    This guidebook is prepared by the Occupational Safety and Health Branch Labour Department This edition May 2005 This guidebook is issued free of charge and can be obtained from offices of the Occupational Safety and Health Branch, Labour Department. It can also be downloaded from http://www.labour.gov.hk/eng/public/content2_9.htm. For enquiries about addresses and telephone numbers of the offices, please call 2559 2297. This guidebook may be freely reproduced except for advertising, endorsement or commercial purposes. Please acknowledge the source as 'The Medical Examination of Divers - A Guide for Physicians', published by the Labour Department. Information on the services offered by the Occupational Safety & Health Council can be obtained through hotline 2739 9000. 21 THE MEDICAL EXAMINATION OF DIVERS A GUIDE FOR PHYSICIANS 20 Contents Page Contents 1 Introduction 3 Physics and Basic Physiology of Diving 4 Pressure 4 Boyle's Law 4 Dalton's Law 4 Henry's Law 4 Bubble Formation 5 Types of Diving Commonly Practised in Hong Kong 6 SCUBA Diving 6 Surface Orientated Diving 6 Saturation Diving 6 Requirements for the Medical Examination 7 Equipment 7 Frequency of Medical Examinations 7 General Considerations 8 Age 8 Gender 8 Morphology 8 Previous Medical History 8 Medications 9 Smoking 9 Alcohol, Drug and Substance Abuse 9 Psychiatric Illness 9 Malignancy 9 HIV Infection 10 Communicable Disease or Other Infections 10 The Systemic Medical Examination 11 Dermatology 11 Otorhinolaryngology 11 Respiratory System 11 Dental 12 Cardiovascular System 12 Exercise Testing 13 Central Nervous System 14 Musculo-skeletal System 14 Gastro-intestinal System 14 Genito-urinary System 15 1 Endocrine System 15 Haematology 16 Vision 16 Medical Certification of Fitness to Dive 18 Recommended Reading 19 2 Introduction An approved code of practice for industrial diving has been issued by the Labour Department to give guidance on the general duties provisions (sections 6A & 6B) of the Factories and Industrial Undertakings Ordinance as applied to industrial diving.
  • Toxicity Associated with Carbon Monoxide Louise W

    Toxicity Associated with Carbon Monoxide Louise W

    Clin Lab Med 26 (2006) 99–125 Toxicity Associated with Carbon Monoxide Louise W. Kao, MDa,b,*, Kristine A. Nan˜ agas, MDa,b aDepartment of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN, USA bMedical Toxicology of Indiana, Indiana Poison Center, Indianapolis, IN, USA Carbon monoxide (CO) has been called a ‘‘great mimicker.’’ The clinical presentations associated with CO toxicity may be diverse and nonspecific, including syncope, new-onset seizure, flu-like illness, headache, and chest pain. Unrecognized CO exposure may lead to significant morbidity and mortality. Even when the diagnosis is certain, appropriate therapy is widely debated. Epidemiology and sources CO is a colorless, odorless, nonirritating gas produced primarily by incomplete combustion of any carbonaceous fossil fuel. CO is the leading cause of poisoning mortality in the United States [1,2] and may be responsible for more than half of all fatal poisonings worldwide [3].An estimated 5000 to 6000 people die in the United States each year as a result of CO exposure [2]. From 1968 to 1998, the Centers for Disease Control reported that non–fire-related CO poisoning caused or contributed to 116,703 deaths, 70.6% of which were due to motor vehicle exhaust and 29% of which were unintentional [4]. Although most accidental deaths are due to house fires and automobile exhaust, consumer products such as indoor heaters and stoves contribute to approximately 180 to 200 annual deaths [5]. Unintentional deaths peak in the winter months, when heating systems are being used and windows are closed [2]. Portions of this article were previously published in Holstege CP, Rusyniak DE: Medical Toxicology.